Next-generation yellow fever vaccine vYF demonstrates similar immunogenicity and safety to licensed YF-VAX in Phase 2 trial. by Feroldi E, Mulligan MJ (...) Frago C et 18 al. in N Engl J Med https://t.co/Wv3r2elRi1 #MedX #MedResearch
RT @NEJM: In a phase 2 trial, a new yellow fever vaccine grown in Vero cells was shown to elicit immunogenicity similar to that of the stan…
RT @NEJM: In a phase 2 trial, a new yellow fever vaccine grown in Vero cells was shown to elicit immunogenicity similar to that of the stan…